Latest Articles about PSCH

Questcor Pharmaceuticals, Inc. (QCOR) Ex-Dividend Date Scheduled for April 18, 2013

NASDAQ.com News — Wed, 17 Apr 2013 17:00:04 Z

Questcor Pharmaceuticals, Inc. ( QCOR ) will begin trading ex-dividend on April 18, 2013. A cash dividend payment of $0.25 per share is scheduled to be paid on April 30, 2013. Shareholders who

West Pharmaceutical Services, Inc. (WST) Ex-Dividend Date Scheduled for April 15, 2013

NASDAQ.com News — Fri, 12 Apr 2013 17:00:04 Z

West Pharmaceutical Services, Inc. ( WST ) will begin trading ex-dividend on April 15, 2013. A cash dividend payment of $0.19 per share is scheduled to be paid on May 01, 2013. Shareholders who

West Pharmaceutical Services, Inc. (WST) Ex-Dividend Date Scheduled for January 18, 2013

NASDAQ.com News — Wed, 16 Jan 2013 19:00:04 Z

West Pharmaceutical Services, Inc. ( WST ) will begin trading ex-dividend on January 18, 2013. A cash dividend payment of $0.19 per share is scheduled to be paid on February 06, 2013.

Questcor Pharmaceuticals, Inc. (QCOR) Ex-Dividend Date Scheduled for December 12, 2012

NASDAQ.com News — Mon, 10 Dec 2012 19:00:04 Z

Questcor Pharmaceuticals, Inc. ( QCOR ) has announced an ex-dividend date of December 12, 2012 and a cash dividend payment of $0.2 per share scheduled for December 21, 2012. Shareholders who

Top Zacks Ranked Healthcare ETF in Focus - ETF News And Commentary

Zacks Equity Research — Tue, 13 Nov 2012 00:01:01 Z

The healthcare sector is considered to be a safe haven in times of economic uncertainty as its goods and services are in demand no matter what the broader conditions are. Thanks to this and

ETFs That Will Haunt Your Portfolio (If You Do Not Buy Them) - Investment Ideas

Eric Dutram — Fri, 26 Oct 2012 09:00:01 Z

As we quickly approach Halloween, markets are looking downright terrifying. Many stocks are displaying gruesome earnings, while some regions of the world, like Europe, are a mere skeleton of

David Kotok: Why I'm Buying Health Care Now

Matt Hougan — Wed, 18 Apr 2012 21:30:27 Z

David Kotok of Cumberland Advisors is one of the most established ETF-focused financial advisors in the world. With $1.9 billion in assets under management and a 39-year track